4D pharma PLC | Mutual Funds
Mutual Funds that own 4D pharma PLC
CF Woodford Equity Income
13,091,131
19.98%
0
0.41%
07/31/2018
Invesco Perpetual UK Invt. Ser. - High Income
9,163,617
13.99%
0
0.18%
03/29/2018
2,691,078
4.11%
11,857
0.59%
07/31/2018
Henderson UK & Europe Funds - UK Equity Income Fund
1,369,828
2.09%
0
0.77%
07/31/2018
JPMorgan Funds - Global Healthcare Fund
1,225,761
1.87%
0
0.1%
05/31/2018
Edinburgh Worldwide Investment Trust Plc
1,086,341
1.66%
0
0.44%
10/31/2017
Old Mutual Woodford Equity Income Fund
943,012
1.44%
0
1.15%
07/31/2018
Henderson Opportunities Trust Plc
817,841
1.25%
0
1.27%
12/31/2017
Baillie Gifford Overseas Growth Fund - Global Discovery Fund
807,561
1.23%
0
0.3%
04/30/2018
Lowland Investment Company Plc
740,853
1.12%
0
0.28%
12/31/2017
| Address |
9 Bond Court
Leeds Yorkshire LS1 2JZ
United Kingdom
|
|
Employees
|
- |
| Website |
http://4dpharmaplc.com |
| Updated |
07/08/2019 |
| 4D Pharma Plc is a pharmaceutical company, which engages in the development of live bio therapeutics. It focuses on the research of MicroRx, its proprietary platform for the discovery of novel live bio therapeutics and the development of its pipeline. The company was founded on January 10, 2014 and is headquartered in Leeds, the United Kingdom. |
